The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Treating Lupus Naturally
KMJNow
2021
https://www.kmjnow.com/news/treating-lupus-naturally/
Over 200,000 Americans suffer from the autoimmune disease systemic lupus erythematosus, commonly called lupus, according to a recent study by researchers at NYU Langone Health In New York City. It is the first study to evaluate how widespread this debilitating disease is in the U.S.
Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis
J Clin Gastroenterol
October 2015
https://www.academia.edu/28700218/Initial_Findings_of_an_Open_Label_Trial_of_Low_Dose_Naltrexone_for_Symptomatic_Mesenteric_Panniculitis
Effects of low-dose naltrexone on feed intake, growth, endocrine and immune parameters in the recently-weaned pig
Masters Thesis, University of Tennessee, Knoxville
December 2015
https://www.semanticscholar.org/paper/Effects-of-low-dose-naltrexone-on-feed-intake%2C-and-Carter/c487fc0f07daaed24e0ba8693e18d37ed369303b
Opioid growth factor and low dose naltrexone impair central nervous system infiltration by CD4+T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis
Exp Biol Med (Maywood)
January 2016
http://www.ncbi.nlm.nih.gov/pubmed/26202376
Functional modulation on macrophage by low dose naltrexone (LDN)
Int Immunopharmacol
October 2016
https://www.ncbi.nlm.nih.gov/pubmed/27561742
Serum [Met 5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone
Exp Biol Med (Maywood)
September 2017
https://pubmed.ncbi.nlm.nih.gov/28766982/
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis
Exp Biol Med (Maywood)
November 2009
https://pubmed.ncbi.nlm.nih.gov/19855075/